We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
-4.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$89.7B
AUM Growth
-$6.37B
Cap. Flow
-$1.25B
Cap. Flow %
-1.39%
Top 10 Hldgs %
19.07%
Holding
4,574
New
72
Increased
2,420
Reduced
1,279
Closed
355

Sector Composition

Rank Sector Weight
1 Technology 21.66%
2 Healthcare 16.22%
3 Financials 13.45%
4 Consumer Discretionary 9.63%
5 Industrials 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMVT icon
3076
Immunovant
IMVT
$8.25B
$225K ﹤0.01%
40,279
+3,266
+9% +$16K
TLH icon
3077
iShares 10-20 Year Treasury Bond ETF
TLH
$10.9B
$225K ﹤0.01%
2,064
+1,074
+108% +$127K
OBSV
3078
DELISTED
ObsEva SA Ordinary Shares
OBSV
$224K ﹤0.01%
1,577,118
+126,812
+9% +$76.3K
PXH icon
3079
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.96B
$223K ﹤0.01%
+13,762
New +$245K
CMAX
3080
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$223K ﹤0.01%
1,051
+10
+1% +$2.02K
DNMR
3081
DELISTED
Danimer Scientific, Inc.
DNMR
$222K ﹤0.01%
1,883
-1,639
-47% -$292K
ALBO
3082
DELISTED
Albireo Pharma Inc
ALBO
$221K ﹤0.01%
11,416
+81
+0.7% +$1.68K
PNT
3083
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$220K ﹤0.01%
28,467
+4,338
+18% +$36.8K
MLNK
3084
DELISTED
MeridianLink
MLNK
$219K ﹤0.01%
13,449
+108
+0.8% +$1.89K
FDD icon
3085
First Trust STOXX European Select Dividend Income Fund
FDD
$908M
$217K ﹤0.01%
23,212
-11,910
-34% -$127K
LOVE
3086
LoveSac
LOVE
$261M
$216K ﹤0.01%
10,572
+1,202
+13% +$36.9K
SRRK icon
3087
Scholar Rock
SRRK
$6.44B
$215K ﹤0.01%
30,965
+14,742
+91% +$123K
TNA icon
3088
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.46B
$215K ﹤0.01%
+7,473
New +$299K
ARTY
3089
iShares Future AI & Tech ETF
ARTY
$3.81B
$214K ﹤0.01%
9,000
CNSL
3090
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$214K ﹤0.01%
51,216
+2,462
+5% +$15.2K
FRPH icon
3091
FRP Holdings
FRPH
$421M
$213K ﹤0.01%
7,820
+58
+0.7% +$1.69K
QIWI
3092
DELISTED
QIWI PLC
QIWI
$212K ﹤0.01%
37,345
CCCC icon
3093
C4 Therapeutics
CCCC
$412M
$211K ﹤0.01%
24,030
+12,366
+106% +$128K
CRDO icon
3094
Credo Technology Group
CRDO
$46.6B
$211K ﹤0.01%
19,139
+521
+3% +$6.87K
PAHC icon
3095
Phibro Animal Health
PAHC
$1.39B
$211K ﹤0.01%
15,824
+112
+0.7% +$1.93K
VXRT
3096
DELISTED
Vaxart
VXRT
$211K ﹤0.01%
96,889
+687
+0.7% +$2.37K
OND icon
3097
ProShares On-Demand ETF
OND
$3.62M
$209K ﹤0.01%
11,777
+322
+3% +$6.65K
TPB icon
3098
Turning Point Brands
TPB
$1.74B
$209K ﹤0.01%
9,790
+67
+0.7% +$1.66K
TCDA
3099
DELISTED
Tricida, Inc. Common Stock
TCDA
$209K ﹤0.01%
19,924
+171
+0.9% +$1.87K
PNTG icon
3100
Pennant Group
PNTG
$1.36B
$208K ﹤0.01%
20,003
+140
+0.7% +$2K

Similar funds

Credit Suisse's Q3 2022 Portfolio in Review

As of Q3 2022, Credit Suisse held 4,574 positions worth $89.7B, down 6.6% from $96.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Credit Suisse's Q3 2022 filing shows 72 new, 2,420 increased, 1,279 reduced and 355 closed positions. Its largest new stake was iShares 0-3 Month Treasury Bond ETF: 431,400 shares worth $43.3M. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $205M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Credit Suisse's largest Q3 2022 buy was iShares 0-3 Month Treasury Bond ETF: 431,400 shares worth $43.3M.
  • Credit Suisse added most to Apple in Q3 2022, an estimated $180M increase.
  • Credit Suisse's biggest Q3 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $205M.
  • Credit Suisse fully exited SailPoint Technologies Holdings, Inc. Common Stock in Q3 2022, selling an estimated $40.9M.
  • Credit Suisse's ten largest holdings make up 19% of its $89.7B portfolio in Q3 2022.
  • Credit Suisse opened 72 new positions and closed 355 in Q3 2022.
  • Credit Suisse's portfolio value fell 6.6% quarter-over-quarter to $89.7B.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.